The high expression of PD-L1 in tumor cells promotes lymph node metastasis and enhances glucose metabolism in tumor cells through the SNAI1/SIRT3 pathway, but PD-L1 has the opposite effect on T-cell glycolysis (42). This evidence concerns the gene SIRT3 and neoplasm.